| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ZTS
|
75.80 | 31.3B | 11.82 | 5.80 | 9.05 | 27.1% | 8.1% | 76 | 77 | 131.36 | +55.0% | 76 | 1.35 |
|
BSX
|
47.10 | 68.3B | 19.15 | 2.64 | 14.17 | 7.0% | 7.8% | 75 | 52 | 68.42 | +33.9% | 71 | 0.43 |
|
HCA
|
409.52 | 88.7B | 12.96 | — | 8.78 | 21.3% | 6.8% | 72 | 76 | 814.79 | +68.3% | 54 | -7.76 |
|
RMD
|
229.40 | 33.1B | 21.78 | 5.10 | 14.81 | 26.8% | 9.1% | 72 | 65 | 259.29 | +9.8% | 98 | 0.13 |
|
CVS
|
97.66 | 124.9B | 25.54 | 1.57 | 14.16 | 7.3% | 6.6% | 70 | 56 | 213.50 | +89.0% | 41 | 0.96 |
|
ELV
|
415.40 | 90.1B | 18.15 | 2.01 | — | 8.3% | 7.4% | 69 | 59 | 756.08 | +60.7% | 60 | 0.69 |
|
DGX
|
240.11 | 26.5B | 24.95 | 3.53 | 14.32 | 9.7% | 8.1% | 68 | 49 | 279.11 | +12.2% | 65 | 0.85 |
|
MCK
|
922.66 | 107.6B | 22.59 | — | 15.63 | 228.4% | 8.3% | 67 | 71 | 1,208.06 | +22.9% | 74 | -3.97 |
|
MDT
|
92.52 | 118.4B | 24.53 | 2.43 | 15.51 | 7.6% | 7.5% | 66 | 46 | 114.92 | +18.2% | 66 | 0.60 |
|
STE
|
227.62 | 22.2B | 27.57 | 3.08 | 14.48 | 9.6% | 8.6% | 65 | 45 | 249.01 | +6.8% | 79 | 0.28 |
|
UNH
|
404.20 | 362.8B | 20.63 | 3.79 | 13.62 | 14.0% | 7.9% | 63 | 59 | 470.59 | +12.3% | 61 | 0.84 |
|
BDX
|
186.89 | 50.9B | 28.97 | 2.01 | 13.81 | 6.8% | 7.1% | 62 | 49 | 255.40 | +24.6% | 52 | 0.77 |
|
CAH
|
247.82 | 57.6B | 37.07 | — | 19.14 | 132.9% | 8.1% | 61 | 70 | 331.55 | +21.6% | 59 | -3.15 |
|
CNC
|
68.37 | 33.8B | — | 1.58 | — | 0.1% | 7.2% | 60 | 61 | 186.93 | +97.1% | 58 | 0.76 |
|
DXCM
|
89.56 | 33.8B | 33.81 | 12.89 | 21.87 | 30.7% | 8.9% | 60 | 56 | 65.37 | -20.3% | 91 | 0.53 |
|
A
|
149.45 | 42.1B | 32.71 | 5.92 | 22.26 | 14.9% | 8.7% | 57 | 42 | 112.23 | -18.7% | 88 | 0.47 |
|
ABT
|
108.62 | 188.0B | 28.81 | 3.69 | 16.42 | 10.3% | 8.3% | 57 | 45 | 109.86 | +0.8% | 85 | 0.25 |
|
BAX
|
25.49 | 13.2B | — | 2.12 | 27.16 | 1.3% | 6.4% | 54 | 50 | 36.06 | +26.5% | 36 | 1.56 |
|
DHR
|
208.51 | 146.6B | 40.58 | 2.87 | 23.58 | 5.9% | 8.0% | 53 | 37 | 190.06 | -6.4% | 71 | 0.33 |
|
EW
|
89.60 | 51.6B | 37.85 | 5.06 | 26.65 | 16.5% | 8.7% | 51 | 37 | 56.79 | -27.5% | 93 | 0.07 |
|
TMO
|
611.04 | 225.9B | 33.71 | 4.43 | 23.06 | 8.4% | 8.0% | 50 | 34 | 479.45 | -16.1% | 66 | 0.70 |
|
SYK
|
308.88 | 118.5B | 36.54 | 5.44 | 22.17 | 11.4% | 8.3% | 50 | 40 | 236.50 | -17.6% | 71 | 0.76 |
|
IQV
|
265.21 | 43.7B | 31.52 | 7.02 | 16.42 | 9.4% | 7.8% | 49 | 44 | 238.40 | -6.8% | 43 | 2.58 |
|
MOH
|
205.99 | 10.8B | — | 2.58 | 26.20 | 6.3% | 7.7% | 49 | 45 | 211.94 | +1.8% | 60 | 0.95 |
|
HUM
|
412.33 | 49.5B | 43.82 | 2.66 | — | 7.3% | 7.9% | 48 | 35 | 387.48 | -3.6% | 49 | 0.75 |
|
ISRG
|
368.08 | 130.0B | 45.53 | 7.30 | 35.90 | 17.0% | 8.7% | 46 | 35 | 196.44 | -35.0% | 98 | 0.00 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.